Sagimet Biosciences Statistics
Total Valuation
SGMT has a market cap or net worth of $109.46 million. The enterprise value is -$39.14 million.
Important Dates
The last earnings date was Wednesday, March 12, 2025, before market open.
| Earnings Date | Mar 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SGMT has 32.20 million shares outstanding. The number of shares has increased by 199.71% in one year.
| Current Share Class | 30.67M |
| Shares Outstanding | 32.20M |
| Shares Change (YoY) | +199.71% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | 10.48% |
| Owned by Institutions (%) | 41.57% |
| Float | 19.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.77 |
| P/TBV Ratio | 0.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 34.30, with a Debt / Equity ratio of 0.00.
| Current Ratio | 34.30 |
| Quick Ratio | 33.96 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -36.92% and return on invested capital (ROIC) is -27.56%.
| Return on Equity (ROE) | -36.92% |
| Return on Assets (ROA) | -26.49% |
| Return on Invested Capital (ROIC) | -27.56% |
| Return on Capital Employed (ROCE) | -34.95% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.25M |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.25% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -35.25% |
| 50-Day Moving Average | 4.06 |
| 200-Day Moving Average | 4.12 |
| Relative Strength Index (RSI) | 44.14 |
| Average Volume (20 Days) | 315,034 |
Short Selling Information
The latest short interest is 4.19 million, so 13.02% of the outstanding shares have been sold short.
| Short Interest | 4.19M |
| Short Previous Month | 4.98M |
| Short % of Shares Out | 13.02% |
| Short % of Float | 21.58% |
| Short Ratio (days to cover) | 8.71 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -54.45M |
| Pretax Income | -27.92M |
| Net Income | -45.57M |
| EBITDA | n/a |
| EBIT | -54.45M |
| Earnings Per Share (EPS) | -$1.45 |
Full Income StatementBalance Sheet
The company has $151.25 million in cash and $78,000 in debt, giving a net cash position of $158.58 million or $4.93 per share.
| Cash & Cash Equivalents | 151.25M |
| Total Debt | 78,000 |
| Net Cash | 158.58M |
| Net Cash Per Share | $4.93 |
| Equity (Book Value) | 155.81M |
| Book Value Per Share | 4.84 |
| Working Capital | 148.32M |
Full Balance SheetCash Flow
| Operating Cash Flow | -42.44M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |